- Home
- MOMO vs TRVI Comparison
MOMO vs TRVI Comparison
Compare MOMO & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOMO
- TRVI
- Stock Information
- Founded
- MOMO 2011
- TRVI 2011
- Country
- MOMO China
- TRVI United States
- Employees
- MOMO N/A
- TRVI N/A
- Industry
- MOMO Computer Software: Prepackaged Software
- TRVI Biotechnology: Pharmaceutical Preparations
- Sector
- MOMO Technology
- TRVI Health Care
- Exchange
- MOMO Nasdaq
- TRVI Nasdaq
- Market Cap
- MOMO 1.2B
- TRVI 1.1B
- IPO Year
- MOMO 2014
- TRVI 2019
- Fundamental
- Price
- MOMO $6.89
- TRVI $10.68
- Analyst Decision
- MOMO Buy
- TRVI Strong Buy
- Analyst Count
- MOMO 2
- TRVI 9
- Target Price
- MOMO $10.00
- TRVI $20.72
- AVG Volume (30 Days)
- MOMO 840.1K
- TRVI 1.7M
- Earning Date
- MOMO 12-08-2025
- TRVI 11-05-2025
- Dividend Yield
- MOMO 4.34%
- TRVI N/A
- EPS Growth
- MOMO N/A
- TRVI N/A
- EPS
- MOMO 0.68
- TRVI N/A
- Revenue
- MOMO $1,459,052,877.00
- TRVI N/A
- Revenue This Year
- MOMO $0.62
- TRVI N/A
- Revenue Next Year
- MOMO $3.85
- TRVI N/A
- P/E Ratio
- MOMO $10.22
- TRVI N/A
- Revenue Growth
- MOMO N/A
- TRVI N/A
- 52 Week Low
- MOMO $5.12
- TRVI $2.36
- 52 Week High
- MOMO $9.22
- TRVI $11.11
- Technical
- Relative Strength Index (RSI)
- MOMO 34.79
- TRVI 68.56
- Support Level
- MOMO $6.73
- TRVI $10.16
- Resistance Level
- MOMO $7.34
- TRVI $11.11
- Average True Range (ATR)
- MOMO 0.17
- TRVI 0.56
- MACD
- MOMO -0.01
- TRVI 0.04
- Stochastic Oscillator
- MOMO 16.85
- TRVI 76.37
About MOMO Hello Group Inc.
Hello Group Inc provides mobile-based social networking services. It enables users to establish and expand social relationships based on location and interests. Its platform includes the Momo mobile application and a variety of related features, functionalities, tools, and services that it provides to users, customers, and platform partners. The company derives its revenue from live video services, value-added services, mobile marketing services, mobile games, and other services. It operates in three segments: Momo's service lines, Tantan's service lines, and QOOL's service lines, out of which Momo's service lines segment derives the majority of revenue.
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.